scholarly journals Long-term survival and costs following extracorporeal membrane oxygenation in critically ill children—a population-based cohort study

Critical Care ◽  
2020 ◽  
Vol 24 (1) ◽  
Author(s):  
Shannon M. Fernando ◽  
Danial Qureshi ◽  
Peter Tanuseputro ◽  
Sonny Dhanani ◽  
Anne-Marie Guerguerian ◽  
...  
BMJ ◽  
2018 ◽  
pp. k1998 ◽  
Author(s):  
Niels Obel ◽  
Ram B Dessau ◽  
Karen A Krogfelt ◽  
Jacob Bodilsen ◽  
Nanna S Andersen ◽  
...  

2015 ◽  
Vol 30 (5) ◽  
pp. 949-956 ◽  
Author(s):  
Aidan J.C. Burrell ◽  
Vincent A. Pellegrino ◽  
Rory Wolfe ◽  
Wen Kai Wong ◽  
David Jamie Cooper ◽  
...  

2019 ◽  
Vol 90 (3) ◽  
pp. e14.2-e14
Author(s):  
JJM Loan ◽  
NW Scott ◽  
JO Jansen

AimTo determine if survival and hospital resource usage differ following traumatic brain injury (TBI) compared with head injury without neurological injury(HI).MethodsThis retrospective population-based cohort study included all 25 319 patients admitted to a Scottish NHS hospital from 1997–2015 with TBI. Participants were identified using previously validated ICD-10 based definitions. For comparison, all 194 049 HI cases were identified. Our main outcome measures were hazards of all-cause mortality after TBI, compared with HI, over 18 years follow-up period; and odds of mortality at one month post-injury. Number of days spent as inpatients and number of outpatient attendances per surviving month post-injury were used as measures of resource utilisation.ResultsThe adjusted odds ratio for mortality in the first month post-injury for TBI was 7.12 (95% confidence interval [CI] 6.73–7.52; p<0.001). For the remaining 18 year study period, the hazards of morality after TBI were 0.93 (CI 0.90–0.96; p<0.001). TBI was associated with 2.15 (CI 2.10–2.20; p<0.001) more days spent as inpatient and 1.09 times more outpatient attendances (CI 1.07–1.11; p<0.001) than HI.ConclusionsAlthough initial mortality following TBI is high, survivors of the first month can achieve comparable long-term survival to HI. However this is associated with increased utilisation of hospital services in the TBI group.


2009 ◽  
Vol 87 (3) ◽  
pp. 854-860 ◽  
Author(s):  
Christian A. Bermudez ◽  
Prasad S. Adusumilli ◽  
Kenneth R. McCurry ◽  
Diana Zaldonis ◽  
Maria M. Crespo ◽  
...  

2020 ◽  
Vol 22 (11) ◽  
pp. 1585-1596
Author(s):  
S. Niemeläinen ◽  
H. Huhtala ◽  
A. Ehrlich ◽  
J. Kössi ◽  
E. Jämsen ◽  
...  

Author(s):  
Amy Johnston ◽  
Thierry G. Mesana ◽  
Douglas S. Lee ◽  
Anan Bader Eddeen ◽  
Louise Y. Sun

2018 ◽  
Vol 8 (4) ◽  
pp. 329-337 ◽  
Author(s):  
Petter Schiller ◽  
Laila Hellgren ◽  
Per Vikholm

Objectives: Survival after different short-term mechanical circulatory support is difficult to compare because various systems are used and patient disease severity is most often not adjusted for. This study compares the outcome after the use of Impella and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in refractory cardiogenic shock, adjusted for disease severity through the survival after the VA-ECMO (SAVE) score. Methods: Patients with refractory shock treated with either VA-ECMO or Impella between January 2003 and August 2015 were included. Data were analysed to assess short and long-term survival and complications. The SAVE score was calculated for the two groups and outcome was compared adjusted for the SAVE score. Results: There was no difference between VA-ECMO patients ( n=46) and Impella patients ( n=48) in mean age or renal failure. ECMO patients were more often intubated and had lower diastolic blood pressure at device implantation. ECMO patients had a lower SAVE score (–0.4 (6.5)) compared to Impella patients (4.1 (5.4)). There was no difference in intensive care unit survival between ECMO patients 65% (52–80) or Impella patients 63% (55–79), or long-term survival between groups. When stratified into worse (III–IV) or better SAVE class (I–II) there was no difference in survival between the groups. Conclusions: Short and long-term survival is not measurably different among patients treated with Impella or VA-ECMO due to refractory cardiogenic shock, after adjustment for disease severity through the SAVE score.


BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
A. Seigneurin ◽  
P. Delafosse ◽  
B. Trétarre ◽  
A. S. Woronoff ◽  
M. Velten ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document